section-00087c8

PIONEERING AS A PHARMACEUTICAL SUPPLIER OF MEDICINAL CANNABIS 01. Providing for Today About Us STATE OF THE ART CULTIVATION AND ADVANCED GENETIC STRAINS 02. Innovations About Us GMP & GACP CERTIFIED CANNABIS PRODUCTS 03. Industry Leading Certification
section-2d62d7f
Products

Both Botanical and oil-based wholesale pharmaceutical product offerings

GMP & GACP Certification

Fully accredited Good Manufacturing Practice and GACP cultivation processes

Executive Team

Senior Executive Leadership Team and Founders

section-cabe089

Eco Equity

About Us

At Eco Equity we intend to become world leaders in the production of medicinal cannabis. Supplying extracts and produce such as GMP-Flower, GMP-Oil to the pharmaceutical industry as an API (Active Pharmaceutical Ingredient) to meet the increasing global demand for a high specification medicinal cannabis product and transform lives.

We are based in the heart of London with rapidly expanding production operations in Africa.

//www.eco-equity.com/wp-content/uploads/2020/10/jp-doran-eco-equity-CEO-1.png
JP Doran //www.eco-equity.com/wp-content/uploads/2019/08/signature.png
section-78ec34f
section-78ec34f

Our Mission

We are passionate about the scientific evidence that proves the potential of medicinal cannabis and we will provide a highly effective API to the pharmaceutical industry for global distribution.

With agreements already in place to supply GACP & EU-GMP certified medicinal cannabis via our cultivation regions that include R&D facilities and an active breeding programme to create proprietary genetic variants of medicinal cannabis.

section-8a582da
section-8a582da

Our Background

We are the first company to hold a medicinal cannabis licence in Zimbabwe.

With our connections and local trust, we feel we have a growing social responsibility to be a part of rebuilding the Zimbabwean economy, you can read more about Our Job Creation and Community Outreach Programs here.

section-11b5ef4
section-11b5ef4

Contact Us

Eco Equity focuses on export to global regions with a heavy destination focus on Europe which is predicted to be the world’s biggest over the next 10 years. According to Prohibition Partners – Europe’s cannabis market is estimated to be worth up to €123 billion by 2028. Eco Equity intends, through first-mover advantage to become the biggest producer of CBD oil in Southern Africa.

To learn more about how to invest, please visit our investment fund-vehicle, JPD Capital.

section-17f7997

FAQ & Information

Get in touch with us here and a member of our team will get back to you within 24 hours.

To stay up to date with all things Eco Equity, including company progress, exciting new clinical discoveries and our latest blogs sent straight to your inbox, follow our social platforms:

For comment, interviews and other press & media related enquiries please contact our PR team at BLJ London jonathang@blj.co.uk or visit their website here.

Do you require medicinal cannabis for yourself or a child? You can learn more about how we can support you via the Eco Equity Foundation here

section-c98d27b

Global Distribution Capacity

15,470

Kg

EU-GMP cannabis flower

1,591

Kg

EU-GMP Oil

6

Strains

In Cultivation
section-5c05d9b

Latest News

Our Blog

Lyphe Group Part II: Jonathan Nadler talks post-Brexit supply chain and reducing prescription costs

Brexit has impacted the nation in many ways as we have quickly learned. However the disruption for patients reliant on medicinal cannabis access being transported from overseas, particularly Europe was an unexpected result. This created a lot of focus in the news and patients across the UK were rightfully concerned .

Acquired licenses to supply the global demand of an effective form of medicinal cannabis to the pharmaceutical industry.

  • 0207 043 1541

  • info@eco-equity.com

  • 120 Moorgate, London, EC2M 6UR

  • Mon-Fri: 9am - 6pm